» Articles » PMID: 26990164

Overweight, Obesity, and Risk of Age-Related Macular Degeneration

Overview
Specialty Ophthalmology
Date 2016 Mar 19
PMID 26990164
Citations 60
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: The aim of this study was to quantify the relationship between categories of body mass index (BMI) and age-related macular degeneration (AMD) risk in different stages.

Methods: MEDLINE, EMBASE, and ISI Web of Science were searched for all eligible studies on the relationship between BMI and incident early or late AMD. The analyses were based on data extracted from study reports. The pooled relative risks (RRs) with 95% confidence intervals (CIs) were calculated to evaluate the strength of this association, and dose-response relationship was assessed by restricted cubic spline.

Results: Seven prospective cohort studies with 1613 cases identified among 31,151 subjects were included. For overweight, the relationship remained insignificant for its association with both early AMD (RR = 0.92, 95% CI: 0.68-1.15; P = 0.54) and late AMD (RR = 1.09, 95% CI: 0.93-1.25; P = 0.18). A marked 32% increase in the risk of developing late AMD was noted among obese individuals (RR = 1.32, 95% CI: 1.11-1.53, P < 0.01), while obesity showed no significant association with early AMD (RR = 0.91, 95% CI: 0.74-1.08; P = 0.67). Furthermore, elevated BMI showed a linear dose-response relation with AMD risk (Pnonlinearity = 0.17), and the AMD risk increased by 2% (RR = 1.02, 95% CI: 1.01-1.04) for each 1 kg/m2 increase in BMI within the overweight and obese BMI ranges.

Conclusions: Excess body weight was weakly associated with increase in the risk of AMD in a dose-dependent fashion, especially for its late stage, indicating that keeping normal body weight and avoiding further weight gain may confer potential protection against this disease.

Citing Articles

Risk factors for wet macular degeneration: a systematic review, with novel insights from the Scottish Heart Health Extended Cohort.

Fitton C, Quigley M, Belch J BMC Ophthalmol. 2025; 25(1):67.

PMID: 39930367 PMC: 11809110. DOI: 10.1186/s12886-025-03868-5.


Association between four anthropometric indices with age-related Macular Degeneration from NHANES 2005-2008.

Xu C, Wu X Lipids Health Dis. 2025; 24(1):11.

PMID: 39799346 PMC: 11724460. DOI: 10.1186/s12944-024-02424-2.


Beneficial Effects of Micronutrient Supplementation in Restoring the Altered Microbiota and Gut-Retina Axis in Patients with Neovascular Age-Related Macular Degeneration-A Randomized Clinical Trial.

Baldi S, Pagliai G, Di Gloria L, Pallecchi M, Barca F, Pieri B Nutrients. 2024; 16(22).

PMID: 39599758 PMC: 11597754. DOI: 10.3390/nu16223971.


Gene therapy for geographic atrophy in age-related macular degeneration: current insights.

Jamil M, Waheed N Eye (Lond). 2024; 39(2):274-283.

PMID: 39578546 PMC: 11751089. DOI: 10.1038/s41433-024-03463-w.


Associations of human blood metabolome with optic neurodegenerative diseases: a bi-directionally systematic mendelian randomization study.

Tong B, Long C, Zhang J, Zhang X, Li Z, Qi H Lipids Health Dis. 2024; 23(1):359.

PMID: 39497194 PMC: 11533396. DOI: 10.1186/s12944-024-02337-0.